Physician profile
Alan Wolcott
NPI 1740292929
$1,756.09
in general payments reported to CMS, 2019-2025
14 companies · $63.40 in 2025
The $63.40 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $107 · 2021: $42.61 · 2022: $764 · 2023: $583 · 2024: $82.80 · 2025: $63.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $326.92 | 2023 | |
| Acteon INC | $280.00 | 2022 | |
| Implant Direct Sybron International LLC | $270.66 | 2022 | |
| Kerr Corporation | $226.32 | 2019-2022 | |
| Nobel Biocare USA | $202.68 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $116.53 | 2019-2025 | Arestin |
| A-Dec, INC. | $98.10 | 2022 | |
| Envista Holdings Corporation | $66.59 | 2024 | Miniendo II, Optibond Solo Plus, Spark |
| Dental Imaging Technologies Corp. | $57.61 | 2022 | |
| Kavo Dental Technologies LLC | $35.09 | 2021-2023 | |
| Dentsply Sirona INC | $29.90 | 2019-2023 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Voco America INC. | $16.65 | 2025 | Meron Plus Qm, Voco Retraction Paste, Voco Profluorid Varnish |
| Ultradent Products INC | $15.49 | 2021 | |
| Gc America INC. | $13.55 | 2025 | Mipaste One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Wolcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.